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advantages of the conventional on-pump coronary
revascularization and set the ground for postoperative
thrombotic complications.
For the past 4 years, we have applied the systematic
use of off-pump coronary artery operations to all cases
of coronary revascularization, with the main contraindi-
cation being the preoperative hemodynamic instability.
More than 95% of all our cases were performed off-
pump during that time. Meanwhile, we have noted an
increased incidence of postoperative thrombotic com-
plications, and this is the object of the present report.
Methods and results
Off-pump operations. Between September 1996 and May
2000, 500 patients were operated on without CPB at the
Montreal Heart Institute by a single surgeon. The average
patient age was 64 ± 10 years, the majority of patients were
male (80%), and the most common surgical indication was
unstable angina (69%). On average, 3.1 grafts per patient
were completed, and internal thoracic artery (ITA) conduits
were used in more than 97% of the cohort. The incidence of
perioperative myocardial infarction (1.7% Q wave) was simi-
lar to that found with conventional CPB operations4 in our
institution, and operative mortality remained low (1.3%).
During the operation, all patients received an initial heparin
dose of 1 mg/kg, with an additional bolus when necessary to
maintain the activated coagulation time above 300 seconds.
B eating heart operations have recently gained popu-larity among the cardiovascular community.
Because the use of a cardiopulmonary bypass (CPB)
apparatus is avoided during these interventions, the
level of anticoagulation required is generally lower than
that found in the standard procedure with CPB. The
CPB-related inflammatory response caused by the acti-
vation of plasma protein systems, such as contact sys-
tem, intrinsic and extrinsic coagulations, complement,
and fibrinolytic system, is accordingly reduced.1 The
usual postoperative CPB-generated coagulopathy does
not occur. Although the temporary precariousness of the
clotting system is generally seen as a negative aspect by
the cardiac surgeons, it may help in preventing throm-
botic complications normally seen after any surgical
procedure. Postoperative hypercoagulability is a well-
documented state after general and orthopedic opera-
tions and is responsible for significant postoperative
morbidity.2,3 The nonuse of CPB may offset some of the
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During the postoperative course, 5 (1.0%) patients had throm-
botic complications, which caused 1 patient’s death (Table I).
Among this group, 3 patients had a pulmonary embolism dur-
ing recovery after the operation.
The first patient, a 52-year-old man, had chronic renal
insufficiency and had been on hemodialysis for many years.
He had a pulmonary embolus, confirmed on the ventilation-
perfusion nuclear scan, on postoperative day 5 after a triple
coronary artery bypass graft. He was successfully treated
with intravenous heparin and continued to receive warfarin
sodium for 3 months.
The second patient was a 54-year-old diabetic man receiv-
ing optimal medical treatment who was operated on for
unstable angina. Twenty-four hours before the operation, an
intra-aortic balloon device was inserted because of persistent
angina. The coronary angiogram revealed a significant left
main stenosis and a significant triple-vessel disease. He was
discharged on postoperative day 5 after an uneventful triple
off-pump coronary artery bypass operation. A few days later,
he was readmitted for a superficial wound infection and kept
in the hospital for intravenous antibiotics. Two days later,
without warning signs, the patient had a cardiac arrest. All
attempts to resuscitate him were unsuccessful, even though
they were immediately initiated. An autopsy revealed a mas-
sive embolism at the pulmonary artery bifurcation with an
extensive right iliofemoral deep venous thrombosis ipsilater-
al to the site of the intra-aortic balloon device. All coronary
artery grafts were found patent at the autopsy.
Another 48-year-old man underwent an elective triple coro-
nary artery bypass with arterial graft only (sequential diago-
nal–left anterior descending arteries with the left ITA and
right coronary artery grafting with the right ITA). The opera-
tion was uneventful, but on the third postoperative day, he
reported a sudden pleuretic pain to the right side of the chest.
Nuclear scan revealed multiple pulmonary emboli, mainly
spread to the right lung. No leg deep vein thrombi were
detected by means of Doppler scanning. He was given anti-
coagulant medications for 3 months.
Two other patients (a 61-year-old woman and a 62-year-old
man), after successful coronary revascularization without
complications for unstable angina, returned with an extensive
iliofemoral deep vein thrombosis (DVT). One of them had an
intra-aortic balloon device installed 24 hours before the oper-
ation because of refractory unstable angina. They were both
anticoagulated with warfarin for 3 months without any other
complications.
No patient had any history of DVT or pulmonary
embolism. No standard prophylactic regimen for preventing
DVT was applied, although 4 of these patients were receiving
intravenous heparin for unstable angina before the operation.
Heparin-induced thrombocytopenia was not suspected in any
of them. No patient received antifibrinolytic drugs before or
during the operation.
CPB operations.To compare the prevalence of postopera-
tive thrombotic complications in off-pump operations with
those in conventional operations, we have revised the inci-
dence of this complication in patients operated on with the
use of CPB at the Montreal Heart Institute. Between April
1998 and March 2000, 1476 patients underwent isolated
coronary artery revascularization with CPB in our institution.
Among them, 8 (0.50%) patients sustained venous throm-
boembolic complications within the first 3 postoperative
months (Table I). Antifibrinolytic drugs were not routinely
used during this period. Among those who presented with
DVT, the majority had the process limited to the
infrapopliteal area. Moreover, 4 patients had significant pre-
disposing factors. Heparin-induced thrombocytopenia was
suspected in 1 patient, a second patient had a perioperative
cerebrovascular accident that left him with right hemiplegia,
a third patient was readmitted with a mediastinitis that
required re-exploration and prolonged hospitalization, and
the fourth patient had an adrenal tumor diagnosed on an
abdominal CT scan. The patient died of a massive pulmonary
embolism, and autopsy was refused by the family. A paraneo-
plastic syndrome was suspected.
Discussion
Tissue damage during major surgical procedures
releases a significant amount of tissue factor into the
venous circulation. As this procoagulant compound
passes through the lung capillaries, a significant
amount of thrombin is generated, which contributes to
postoperative hypercoagulability.2 Animal studies have
shown that damage to bone marrow could be a major
factor in postoperative hypercoagulability.5 This is par-
ticularly significant in cardiac operations, in which a
standard sternotomy approach is routinely used. The
median sternotomy frequently induces significant
bleeding through the bone section and encourages
seeding of procoagulant factors across the surgical
field. Locally, it induces the release of thrombin-
antithrombin complexes and increases tissue plasmin
activator. Furthermore, high thrombin generation has
been associated with coronary artery disease, along
with the presence of high tissue factor levels.6 All these
factors directly contribute to create a postoperative
phase of hypercoagulability.
Some of our patients in the off-pump cohort had pre-
disposing factors, such as chronic renal failure and the
insertion of an intra-aortic balloon device before the
Table I. Prevalence of venous thromboembolic 
complications in off-pump coronary artery bypass
operations and CPB operations
Venous thrombosis
Infrapopliteal Iliofemoral PE Total (%)
OPCAB (n = 500) – 2 3 5 (1.0)
CPB (n = 1476) 4 1 3 8 (0.5)*
OPCAB, Off-pump coronary artery bypass.
*P = .42.
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operation. However, none of these patients were obese,
they were all younger than 70 years of age, none had a
history of DVT, and 1 was even admitted the day of the
operation. Conversely, predisposing factors for DVT
appeared more frequently in the conventional group,
although patients in both groups were given coated
aspirin early after the operation (<6 hours). Because most
of our patients at the Montreal Heart Institute do not meet
the classic criteria for systematic evaluation of throm-
bophilia, we do not screen our patients for prothrombot-
ic syndrome. Furthermore, the incidence of these disor-
ders is low in the general white population, representing
0.14% to 0.9% for protein C deficiency, 0.7% for protein
S deficiency, 0.17% for antithrombin III deficiency, 5%
for factor V Leinden mutation in heterozygous form,
2.3% for the prothrombin gene mutation (G20210A), and
9% to 10% for hyperhomocysteinemia.7 Consequently,
beside hyperhomocysteinemia, the association between a
congenital hypercoagulable state and the thrombotic
episodes of our patients is unlikely and still does not
explain, by itself, the apparent excess of thrombosis in the
off-pump cohort. It is also noteworthy that this potential
hypercoagulable state did not translate into an increased
prevalence of perioperative myocardial infarction in the
off-pump cohort.
Although thromboembolic complications appear
more frequently in our off-pump coronary artery oper-
ation cohort, this did not reach statistical significance
when compared with the cohort undergoing conven-
tional operations. The 1% incidence of venous throm-
boembolic complication that we observed represents
only those that were clinically obvious cases without
any specific postoperative screening and consequently
does not rule out any subclinical active cases.
Interestingly, in a recent collective review on preven-
tion in venous thromboembolism,3 no specific recom-
mendations were made for cardiac patients undergoing
coronary artery operations, suggesting that DVT pre-
vention has never been seen as a necessity by cardiac
surgeons. Classically, general surgical and orthopedic
patients are considered at high risk for DVT. The most
recommended prophylaxis consists of low-dose unfrac-
tionated heparin (ie, 5000 units given every 8 to 12
hours and commencing 1 to 2 hours before the opera-
tion) or, alternatively, low-molecular-weight heparin.3
These regimens have shown a reduction of relative risk
of DVT of 68% to 72%.
Currently, although the incidence of postoperative
thromboembolic complications in off-pump coronary
artery operations remains low, the associated morbidi-
ty deserves consideration. Consequently, we have
recently opted for a standard prophylactic anticoagula-
tion regimen (subcutaneous heparin 5000 units 3 times
a day starting 1 to 2 hours before the operation) that we
generally maintain until the patient is discharged. More
studies are needed on these topics to substantiate our
preliminary observations and define the optimal pro-
phylactic therapy in coronary artery bypass grafting
operations.
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